These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3266994)

  • 1. Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.
    Saxne T; Di Giovine FS; Heinegård D; Duff GW; Wollheim FA
    J Autoimmun; 1988 Aug; 1(4):373-80. PubMed ID: 3266994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
    Saxne T; Heinegård D; Wollheim FA; Pettersson H
    Lancet; 1985 Jul; 2(8447):127-8. PubMed ID: 2862321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human arthritic synovial fluid influences proteoglycan biosynthesis and degradation in organ culture of bovine nasal cartilage.
    Saxne T; Heinegård D; Wollheim FA
    Coll Relat Res; 1988 May; 8(3):233-47. PubMed ID: 3396307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of insulin-like growth factor (IGF) binding protein-3 in rheumatoid arthritis synovial fluid inhibit stimulation by IGF-I of articular chondrocyte proteoglycan synthesis.
    Neidel J; Blum WF; Schaeffer HJ; Schulze M; Schönau E; Lindschau J; Föll J
    Rheumatol Int; 1997; 17(1):29-37. PubMed ID: 9194211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
    Bell MC; Carroll GJ
    J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.
    Saxne T; Heinegård D; Wollheim FA
    Ann Rheum Dis; 1986 Jun; 45(6):491-7. PubMed ID: 3729574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions.
    Saxne T; Heinegård D
    Arthritis Rheum; 1992 Apr; 35(4):385-90. PubMed ID: 1373620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood.
    Saxne T; Heinegård D
    Br J Rheumatol; 1992 Sep; 31(9):583-91. PubMed ID: 1381980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis.
    Horiuchi T; Yoshida T; Koshihara Y; Sakamoto H; Kanai H; Yamamoto S; Ito H
    Endocr J; 1999 Oct; 46(5):643-9. PubMed ID: 10670749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease.
    Rampart M; Herman AG; Grillet B; Opdenakker G; Van Damme J
    Lab Invest; 1992 Apr; 66(4):512-8. PubMed ID: 1583890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis.
    Bensouyad A; Hollander AP; Dularay B; Bedwell AE; Cooper RA; Hutton CW; Dieppe PA; Elson CJ
    Ann Rheum Dis; 1990 May; 49(5):301-7. PubMed ID: 2344209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
    Rainsford KD; Ying C; Smith FC
    J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
    Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
    J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1-induced interleukin-6 is required for the inhibition of proteoglycan synthesis by interleukin-1 in human articular cartilage.
    Nietfeld JJ; Wilbrink B; Helle M; van Roy JL; den Otter W; Swaak AJ; Huber-Bruning O
    Arthritis Rheum; 1990 Nov; 33(11):1695-701. PubMed ID: 2242066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I accelerates recovery of articular cartilage proteoglycan synthesis in culture after inhibition by interleukin 1.
    Neidel J; Schulze M; Sova L
    Arch Orthop Trauma Surg; 1994; 114(1):43-8. PubMed ID: 7696049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment.
    Saxne T; Heinegård D; Wollheim FA
    Arthritis Rheum; 1987 Sep; 30(9):972-9. PubMed ID: 3663262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis.
    Rooney M; Symons JA; Duff GW
    Rheumatol Int; 1990; 10(5):217-9. PubMed ID: 2075374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies.
    Bertazzolo N; Punzi L; Stefani MP; Cesaro G; Pianon M; Finco B; Todesco S
    Agents Actions; 1994 Mar; 41(1-2):90-2. PubMed ID: 8079829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.